Lai CE, Leahy TP, Turner AJ, Thomassen A, et al. Effectiveness of olutasidenib versus ivosidenib in patients with mutated isocitrate dehydrogenase 1 acute myeloid leukemia who are relapsed or refractory to venetoclax: the 2102-HEM-101 trial versus a US electronic health record-based external control Leuk Lymphoma 2025 Jun 13:1-12. doi: 10.1080/10428194.2025.2514894.
PMID: 40511494